Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine.
Desoutter J, Gay J, Berthon C, Ades L, Gruson B, Geffroy S, Plantier I, Marceau A, Helevaut N, Fernandes J, Bemba M, Stalnikiewicz L, Frimat C, Labreuche J, Nibourel O, Roumier C, Figeac M, Fenaux P, Quesnel B, Renneville A, Duhamel A, Preudhomme C.
Desoutter J, et al. Among authors: stalnikiewicz l.
Leukemia. 2016 Jun;30(6):1416-8. doi: 10.1038/leu.2015.314. Epub 2015 Nov 19.
Leukemia. 2016.
PMID: 26582646
No abstract available.